CD8A and systemic lupus erythematosus: Indeed, in patients with systemic lupus erythematosus, rapamycin treatment has been shown to improve the disease, associated with an increase of Treg and CD8+ memory T cells and a decrease of pro-inflammatory CD4+ and CD8+ T cells [130].